{
    "title": "106_s2776",
    "content": "The \"Medical Research Investment Act of 2000\" increases the limitation on charitable deduction for contributions for medical research. The \"Medical Research Investment Act of 2000\" increases the limitation on charitable deduction for contributions for medical research to 80 percent of the taxpayer's contribution base for any taxable year. The taxpayer's contribution base for the taxable year can exceed charitable contributions allowable. Excess contributions can be carried over for 10 years as medical research contributions. Capital gain property contributions are subject to specific rules. The taxpayer's contribution base can exceed allowable charitable contributions and excess contributions can be carried over for 10 years as medical research contributions of capital gain property to eligible organizations for conducting medical research. The Internal Revenue Code of 1986 is amended to include provisions for medical research contributions, allowing for deductions and carryovers for contributions to eligible organizations conducting medical research. The Internal Revenue Code of 1986 is amended to include provisions for medical research contributions, allowing deductions for contributions made after December 31, 2000. Contributions made on or before December 31, 2000, are eligible for deductions if they would have been allowed under section 170 of the Code for taxable years beginning after December 31, 1999. SEC. 3. Treatment of certain incentive stock options. Treatment of incentive stock options under the Internal Revenue Code of 1986 is amended to include an exception for certain medical research stock transfers. This exception applies to stock traded on an established securities market. The term 'medical research stock transfer' refers to the transfer of stock traded on an established securities market or acquired through the exercise of an incentive stock option in the same taxable year, and which is a medical research contribution as defined in section 170(b)(1)(G)(iv). This amendment adds a nonrecognition provision for certain incentive stock options in the Internal Revenue Code of 1986. The amendment adds a provision for medical research stock transfers in the Internal Revenue Code of 1986, treating them as meeting certain requirements for incentive stock options. The effective date for these amendments is after the enactment of this Act."
}